UPDATE : Wednesday, July 15, 2020
상단여백
Samsung Biologics to develop 5 more cancer therapies of ImmuneOncia
Samsung Biologics said Wednesday that it has signed a CDO (contract develop...
by Shim Hyun-tai  |  2020-07-15 18:33
라인
Biogen, Esai to test another Alzheimer’s drug in phase-3 study
Biogen and Eisai, whose collaboration for experimental Alzheimer’s drug adu...
by Kim Yun-mi  |  2020-07-15 12:42
라인
Medytox, Daewoong keep brawling over US agency’s ruling
Medytox and Daewoong Pharmaceutical continued to brawl over the U.S. Intern...
by Lee Han-soo  |  2020-07-14 17:30
라인
Hanmi Science, Bioapp to start full-scale development of Green bio-based COVID-19 vaccine
Hanmi Science (CEO Lim Chong-yoon, Hanmi Group Holding Company) and a promi...
by Lee Han-soo  |  2020-07-14 14:58
라인
LSK Global PS chosen as CRO of IVI's Covid-19 vaccine trials
LSK Global Pharma Services (PS) said that it would conduct and support the ...
by Lee Han-soo  |  2020-07-13 15:48
라인
‘Remdesivir cut death risk by 62% in severely ill Covid-19 patients’
Gilead Sciences said its Covid-19 drug candidate remdesivir reduced the ris...
by Kim Yun-mi  |  2020-07-13 14:44
라인
Regulator OKs Samyang’s breast cancer treatment
Samyang Biopharmaceuticals said that the Ministry of Food and Drug Safety h...
by Lee Han-soo  |  2020-07-13 14:38
라인
Multinational drugmakers seek to form new trade union
Some workers at the Korean offshoots of multinational pharmaceutical compan...
by Kim Yun-mi  |  2020-07-13 11:44
라인
Ministry OKs Dongkook's P3 trial into benign prostatic hyperplasia treatment
Dongkook Pharmaceutical said that the Ministry of Food and Drug Safety has ...
by Lee Han-soo  |  2020-07-10 16:54
라인
Court rejects Medytox's request not to revoke license of Medytoxin
A local court on Wednesday has turned down Medytox's appeal for suspend...
by Lee Han-soo  |  2020-07-10 14:59
라인
'Xolair’s reimbursement will change treatment paradigm for asthma patients'
Novartis Korea will be able to strengthen its position in the severe allerg...
by Lee Han-soo  |  2020-07-09 18:11
라인
Drugmakers appeal limited insurance benefit for dementia drug choline alfoscerate
Sixty-six manufacturers of choline alfoscerate, a dementia drug, filed an a...
by Kim Chan-hyuk  |  2020-07-09 12:52
라인
‘Hypertension drug Opsumit enhances right ventricle function’
Opsumit (ingredient: macitentan), a pulmonary arterial hypertension (PAH) t...
by Shim Hyun-tai  |  2020-07-08 16:59
라인
Crystal Genomics confirms safety of super-bacteria antibiotic candidate
Crystal Genomics said that it has completed the phase 1 clinical trial for ...
by Lee Han-soo  |  2020-07-08 16:58
라인
‘Study results on MSD’s Keytruda very disappointing’
Local experts expressed dissatisfaction with MSD’s Keynote-604 trial result...
by Kim Yun-mi  |  2020-07-07 16:43
라인
ITC ruling gives Medytox upper hand in BTX strain dispute
Medytox said Tuesday that the U.S. International Trade Commission ruled in ...
by Lee Han-soo  |  2020-07-07 11:47
라인
Daewoong to conduct P1 trial of Covid-19 treatment in Indonesia
Daewoong Pharmaceutical said that the Indonesian health regulators have app...
by Lee Han-soo  |  2020-07-06 16:52
라인
Regulator OKs Janssen's multiple myeloma treatment
Janssen Pharmaceutical said the Ministry of Food and Drug Safety has approv...
by Lee Han-soo  |  2020-07-06 15:48
라인
Experts showed mixed preferences between 2 diabetes treatments
Two classes of drugs -- sodium-glucose cotransporter-2 (SGLT2) inhibitors a...
by Kim Yun-mi  |  2020-07-06 14:20
라인
[News Focus] Who will win BTX strain dispute – Daewoong or Medytox?
The U.S. International Trade Commission (ITC) is to give a preliminary ruli...
by Kim Chan-hyuk  |  2020-07-06 11:50
여백
여백
여백
Back to Top